Filing Details
- Accession Number:
- 0001349929-17-000096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-11 17:03:29
- Reporting Period:
- 2017-12-08
- Accepted Time:
- 2017-12-11 17:03:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1349929 | Cancer Genetics Inc | CGIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 897464 | John Pappajohn | 201 Route 17 North 2Nd Floor Rutherford NJ 07070 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2017-12-08 | 150,000 | $1.86 | 2,781,204 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.842 to $1.862, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
